News | April 21, 2008

Door-to-Balloon Time Faster During Daytime Hours

April 22, 2008 - Heart attack patients receive faster and more comprehensive care if they arrive at the emergency room during the day, according to a review of more than 62,000 cases in the journal Circulation.

Patients arriving during off-hours had to wait longer for treatment to unblock arteries or for bypass surgery to reroute damaged vessels than those arriving during regular hours, the researchers found. Still, speed didn't always translate into better survival.

The patients who arrived during off hours were 7 percent less likely to undergo emergency angioplasty, and 6 percent less likely to undergo coronary artery bypass graft compared with those arriving during regular hours. Although 54 percent of heart attack patients are admitted during off hours, they can expect slower and worse treatment, researchers said.

"Our findings should compel healthcare providers and policy makers to work toward reducing the existing disparities in cardiac care with respect to arrival time," said Hani Jneid, M.D., an interventional cardiology physician-in-training at the Massachusetts General Hospital in Boston.

Dr. Jneid examined data on 62,814 heart attack patients in a database of the American Heart Association. The researchers looked at differences in medical care and death among heart attack patients admitted between 7 a.m. and 7 p.m. on weekdays versus off hours including weeknights, weekends and holidays.

Procedures using balloon catheters to widen blood vessels are the first choice of therapy for patients having had a heart attack caused by a blocked artery. While physicians aim at opening the artery within 90 minutes, the average time from when the patient entered the hospital to when he or she received procedures to treat diseased arteries, or PCI, was 110 minutes during off hours compared with 85 minutes during regular hours. Patients arriving during off hours were 66 percent less likely to get angioplasty within the recommended 90 minutes.

Still, the rate of in-hospital death was similar with 7.1 percent for patients arriving during off-hours versus 7.2 percent for those being admitted during the day.

"It is particularly interesting to note that the observed delays in primary PCI did not translate into measurable differences in in-hospital outcome," Dr. Jneid said. "This seems to run counter to previous study findings."

A study published in February of patients already in the hospital found that those who suffer cardiac arrest at night or on weekends are more likely to die than those whose hearts stop during hospital weekday shifts. That study in the Journal of the American Medical Association analyzed 86,748 in-hospital cardiac arrests from January 2000 to February 2007. The authors urged hospital administrators to spread resources more evenly across all hospital shifts.

In a separate study published in the Archives of Surgery, Rocco Ricciardi from the Lahey Clinic, a Tufts University affiliate in Burlington, MA, found that the percentage of patients dying after bypass surgery fell to 3.3 percent in 2003 from 5.4 percent in 1988, regardless of the number of procedures the hospital performed.

Source: By Chantal Britt,

For more information:

Related Content

Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Lutonix 035 Drug Coated Balloon Earns Additional FDA Premarket Approval
Technology | Drug-Eluting Balloons| August 29, 2017
C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study o
Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Artery Disease (PAD)| May 17, 2017
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon...
Overlay Init